Works by Takimoto, C. H.


Results: 4
    1
    2
    3

    P1276: DOSE RESPONSE PROFILE OF IGM‐2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON‐HODGKIN'S LYMPHOMA.

    Published in:
    HemaSphere, 2022, v. 6, p. 1161, doi. 10.1097/01.HS9.0000847968.95263.25
    By:
    • Leabman, M. K.;
    • Hernandez, G.;
    • Ng, C. M.;
    • Tang, J.;
    • Pandya, D.;
    • Hart, K. C.;
    • Li, K.;
    • Hinton, P. R.;
    • So, J.;
    • Qazi, I.;
    • Cheah, C. Y.;
    • Kim, W. S.;
    • Budde, E.;
    • Gopal, A. K.;
    • Manley, T.;
    • Takimoto, C. H.;
    • Sinclair, A. M.;
    • Carroll, S. F.;
    • Keyt, B. A.;
    • Kotturi, M. F.
    Publication type:
    Article
    4